Bioeconomy

Queensland researchers and farmers are teaming up to design nanotechnology that repurposes agricultural waste into high-value soil products.

AIBN researchers are using the latest sequencing technology developed by UK-based biotech Oxford Nanopore Technologies to analyse mRNA vaccines and therapies.

Hemanshi Galaiya's work in synthetic biology is just part of the wider picture of how she is changing the world.

AIBN researchers are hoping to turn the tide on ocean waste with customised seawater-degradable plastics made using 3D-printing techniques.

mRNA vaccines and therapies will be produced for clinical trials in a dedicated laboratory to be built at the Australian Institute for Bioengineering and Nanotechnology.

Designing a new biodegradable ‘plastic’ bag could help change the way we farm mushrooms and open lucrative opportunities in packaging and manufacturing.

Researchers at the Australian Institute for Bioengineering and Nanotechnology have pioneered a simple, fast and effective technique to remove PFAS chemicals from water.  

A new $280 million Translational Science Hub will transform the Queensland biomedical ecosystem and create the next generation of mRNA cures.

University of Queensland researchers have pioneered a new chemical process to manufacture the molecules that are the building blocks for lifesaving medicines, vaccines and energy storage materials.

The success of mRNA vaccines and cell therapies has highlighted the importance of biotechnology, and AIBN has helped kick-start the process for establishing a biomanufacturing ecosystem for Queensland.